References
- Andrews AM, Ladenheim B, Epstein CJ, Cadet JL, Murphy DL. 1996. Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 20-NH2-MPTP on serotonergic and noradrenergic nerve terminals. Mol Pharmacol 50:1511–1519.
- Barkey RJ, Amit T, Ben-Shachar D, Youdim MB. 1986. Characterization of the hepatic prolactin receptors induced by chronic iron deficiency and neuroleptics. Eur J Pharmacol 122:259–267.
- Beard JL. 2001. Iron biology in immune function, muscle metabolism, and neuronal functioning. J Nutr 131:568S-580S.
- Beard JL, Connor JR. 2003. Iron status and neural functioning. Annu Rev Nutr 23:41–58.
- Beard JL, Connor JR, Jones BC. 1993. Iron in the brain. Nutr Rev 51:157–170.
- Beard JL, Chen Q, Connor JR, Jones BC. 1994. Altered monoamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol Biochem Behav 48:621–624.
- Beard JL, Erikson KM, Jones BC. 2002. Neurobehavioral analysis of developmental iron deficiency in rats. Behav Brain Res 134:517–524.
- Beard JL, Erikson KM, Jones BC. 2003. Neonatal iron deficiency results in irreversible changes in dopamine function in rats. J Nutr 133:1174–1179.
- Brandao ML, Troncoso AC, de Souza Silva MA, Huston JP. 2003. The relevance of neuronal substrates of defense in the midbrain tectum to anxiety and stress: Empirical and conceptual considerations. Eur J Pharmacol 463:225–233.
- Chen Q, Beard JL, Jones BC. 1995. Abnormal rat brain monoamine metabolism in iron deficiency anemia. J Nutr Biochem 6:486–493.
- Dringenberg HC, Dennis KE, Tomaszek S, Martin J. 2003. Orienting and defensive behaviors elicited by superior colliculus stimulation in rats: Effects of 5-HT depletion, uptake inhibition, and direct midbrain or frontal cortex application. Behav Brain Res 144:95–103.
- Earley CJ, Allen RP, Beard JL, Connor JR. 2000. Insight into the pathophysiology of restless leg syndrome. J Neurosci Res 62:623–628.
- Erikson KM, Pinero DJ, Connor JR, Beard JL. 1997. Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J Nutr 127:2030–2038.
- Erikson KM, Jones BC, Beard JL. 2000. Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 130:2831–2837.
- Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. 2001. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav 69:409–418.
- Felt BT, Lozoff B. 1996. Brain iron and behavior of rats are not normalized by treatment of iron deficiency anemia during early development. J Nutr 126:693–701.
- Garris DR. 2003. Aggression-associated changes in murine olfactory tubercle bioamines. Brain Res 963:150–155.
- Kaladhar M, Rao BS. 1982. Effects of iron deficiency on serotonin uptake in vitro by rat brain synaptic vesicles. J Neurochem 38:1576–1581.
- Kaladhar M, Rao BS. 1983. Effect of maternal iron deficiency in rat on serotonin uptake in vitro by brain synaptic vesicles in the offspring. J Neurochem 40:1768–1770.
- Kwik-Uribe CL, Gietzen D, German JB, Golub MS, Keen CL. 2000. Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J Nutr 130:2821–2830.
- Morse AC, Beard JL, Azar MR, Jones BC. 1999. Sex and genetics are important cofactors in assessing the impact of iron deficiency on the developing mouse brain. Nutr Neurosci 2:323–335.
- de Oliveira LB, De Luca Jr., LA, Menani JV. 2003. Moxonidine and central alpha2 adrenergic receptors in sodium intake. Brain Res 993:177–182.
- Pinero DJ, Li NQ, Connor JR, Beard JL. 2000. Variations in dietary iron alter brain iron metabolism in developing rats. J Nutr 130:254–263.
- Powers KM, Smith-Weller T, Franklin GM, Longstreth Jr., WT, Swanson PD, Checkoway H. 2003. Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60:1761–1766.
- Reith MA. 2000. Neurotransmitter Transporters. New Jersey: Humana Press.
- Shukla A, Agarwal KN, Chansuria JPN, Taneja V. 1989. Effect of latent iron deficiency on 5-hydroxytryptamine metabolism in rat brain. J Neurochem 52:730–735.
- Sobotka TJ, Whittaker P, Sobotka JM, Brodie RE, Quander DY, Robl M, Bryant M, Barton CN. 1996. Neurobehavioral dysfunctions associated with dietary iron overload. Physiol Behav 59:213–219.
- Tejani-Butt SM. 1992. [3H] Nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J Pharmacol Exp Ther 260:427–436.
- Tordoff DG. 1992. Salt intake of rats fed diets deficient in calcium, iron, magnesium, phosphorus, potassium, or all minerals. Appetite 18:29–41.
- Watanabe A, Tohyama Y, Nguyen KQ, Hasegawa S, Debonnel G, Diksic M. 2003. Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: An autoradiographic study. J Neurochem 85:469–475.
- Wiesinger J, Connor JR, Beard JL. 2002. Iron chelation decreases DA transporter density in PC12 and neuroblastoma cells. FASEBJ 16:A22.
- Youdim MBH, Green AR. 1978. Iron deficiency and neurotransmitter synthesis and function. Proc Nutr Soc 37:173–179.
- Youdim MBH, Green AR, Bloomfield MR, Mitchell BD, Heal DJ, Grahame-Smith DG. 1980. The effects of iron deficiency on brain biogenic monoamine biochemistry and function in rats. Neuropharmacology 19:259–267.